Micromet Investor Sues To Halt $1.2B Amgen Purchase
A shareholder of cancer drug specialist Micromet Inc. launched a class action in Delaware state court on Monday to halt biotech giant Amgen Inc.'s $1.16 billion purchase of Micromet, saying the...To view the full article, register now.
Already a subscriber? Click here to view full article